TIMING OF INITIATION OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND ASPIRIN ADMINISTRATION ON THE PREGNANCY OUTCOMES IN WOMEN WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND RECURRENT ABORTI - Egyptian Knowledge Bank

260978

TIMING OF INITIATION OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND ASPIRIN ADMINISTRATION ON THE PREGNANCY OUTCOMES IN WOMEN WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND RECURRENT ABORTI

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Low-Molecular–Weight Heparin versus Unfractionated Heparin in Pregnant Women with Recurrent Abortion associated with Antiphospholipid Syndrome

Article

Aspirin versus low molecular weight heparin for secondary prevention of venous thromboembolism in pregnancy

Article

Effect of Sildenafil Citrate When Added to Low Molecular Weight Heparin and Small Dose Aspirin on Uteroplacental Perfusion in Cases of High-Risk Pregnancy

Article

Role of low molecular weight of heparin in preventing severe preeclampsia

Article

Combined Low Dose Aspirin and Steroids vs Aspirin Only in Management of Unexplained Recurrent Miscarriage

Article

Effect of Low Dose Aspirin Therapy on Pregnancy Rate in Women Undergoing in vitro Fertilization: A Randomised Controlled Trial

Article

Effect of Low Dose Aspirin on Luteal Phase Uterine Artery Doppler Indices in Women with Recurrent Pregnancy Loss

Article

Anticardiolipin and Anti-(32 Glycoprotein I Antibodies in Pregnant Women with Severe Pre-Eclampsia

Article

The Placental Vascularization Indices Value and Placental Volume in Pregnancies with Antiphospholipid Syndrome for Pregnancy Outcome Prediction

Article

Combined Low Dose Aspirin and 17 α Hydroxyl Progesterone versus 17 α Hydroxyl Progesterone Alone Study in Pregnancy: A Randomized Clinical Trial for Prevention of Spontaneous Pre